Heregulin, a ligand of HER receptors and more specifically of ErbB3 and ErbB4, which is essential for ErbB2 phosphorylation in response to heregulin [37], is involved in the progression of different types of human cancers [38] and induces the spread of breast cancer cells in vivo [39]. Here, ERBB4 is linked to breast carcinoma.